Intracerebral Hemorrhage Clinical Trials

16 studies are recruiting for intracerebral hemorrhage in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

    The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Barrow Neurological Institute, Phoenix, Arizona
    Locations
    31 in total
    Run by
    Massachusetts General Hospital
  2. CoMind Early Feasibility Study

    The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pres…

    Stage
    Not phased
    Ages
    18 and older
    Site
    UC Davis Medical Center, Sacramento, California
    Locations
    16 in total
    Run by
    CoMind Technologies Limited
  3. Rapid Evacuation and Access of Cerebral Hemorrhage Registry

    The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Grady Memorial Hospital, Atlanta, Georgia
    Run by
    Emory University
  4. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

    The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is tha…

    Stage
    Phase 3
    Ages
    18 to 80
    Site
    University of Alabama Hospital, Birmingham, Alabama
    Locations
    89 in total
    Run by
    Joseph Broderick, MD
  5. Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?

    The principal objective of this study is to compare the incidence of ventriculostomy related infections (VRIs) in patients who receive twenty-four hours of antibiotics, beginning no more than sixty minutes prior to EVD placement, to the incidence of VRIs in patients who also receive a pre-procedura…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Montefiore Medical Center, The Bronx, New York
    Run by
    Montefiore Medical Center
  6. Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

    The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.

    Stage
    Not phased
    Ages
    18 to 100
    Site
    University of California, Irvine, California
    Locations
    20 in total
    Run by
    Zeenat Qureshi Stroke Institute
  7. Auricular VNS Following Intracerebral Hemorrhage

    This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Washington University School of Medicine, St Louis, Missouri
    Run by
    Washington University School of Medicine
  8. Improving Outcomes for Patients With Life-Threatening Neurologic Illness

    Background: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without proper scientific support. This can be partly explained by the fact that mechanisms of initial brain injury are still not well understood. …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Maryland Medical Center, Baltimore, Maryland
    Run by
    University of Maryland, Baltimore
  9. International Care Bundle Evaluation in Cerebral Hemorrhage Research

    Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, intensive care and neur…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    The University of Oklahoma Health, Oklahoma City, Oklahoma
    Locations
    54 in total
    Run by
    Region Skane
  10. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Alabama Hospital, Birmingham, Alabama
    Locations
    187 in total
    Run by
    Yale University
  11. Evaluating a Prototype CT Scan for ICH Evacuation

    The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of th…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mount Sinai West, New York, New York
    Run by
    Icahn School of Medicine at Mount Sinai
  12. Statins In Intracerbral Hemorrhage

    The SATURN trial aims to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by an individual's Apolipoprotein-E (APOE) genotype.…

    Stage
    Phase 3
    Ages
    50 and older
    Site
    Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Run by
    Beth Israel Deaconess Medical Center
  13. Hemodynamic ABI Monitor

    The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Particip…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  14. Augmented Renal Clearance in Neurocritical Care

    Stroke, severe brain injury, uncontrolled seizures and brain infections are the most common life-threatening neurological illnesses in the world with an estimated combined annual hospital management cost of up to 44 billion dollars. Seizures and infections are common complications following acute n…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    UK HealthCare, Lexington, Kentucky
    Locations
    3 in total
    Run by
    University of Alberta
  15. Effect of the Stellate Ganglion Block on the Retinal Microcirculation

    Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain …

    Stage
    Not phased
    Ages
    18 and older
    Site
    UT Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  16. Short-term And Longer-term Cognitive Impact Of Neurochecks

    The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain injury (ABI). In current practice, the neurocritical care community performs frequent serial neurological examinations ("neurochecks") in an…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    UC San Diego Health, San Diego, California
    Run by
    University of California, San Diego

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.